SCHEMBL2482974

SCHEMBL2482974

COc1ccc(F)cc1CNc1cc(Nc2ccc(N3CCOCC3)cc2)ncc1C(N)=O

nearest known ligand 0.61

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
STAT6 P42226 15/20 0.61
MAPK10 P53779 3/20 0.51
MAPK9 P45984 1/20 0.51
JAK3 P52333 1/20 0.50
IRAK4 Q9NWZ3 1/20 0.50
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2472290 0.92 STAT6 (0.72) STAT6MAPK10MAPK9GAA
SCHEMBL2483337 0.90 STAT6 (0.73) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2480873 0.88 STAT6 (0.62) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2479620 0.88 STAT6 (0.73) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2484601 0.85 STAT6 (0.70) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2478758 0.84 STAT6 (0.71) STAT6MAPK10MAPK9
SCHEMBL2481818 0.84 STAT6 (0.72) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2486643 0.83 STAT6 (0.73) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2478948 0.83 STAT6 (0.61) STAT6MAPK10MAPK9JAK3IRAK4
SCHEMBL2485940 0.83 STAT6 (0.61) STAT6MAPK10MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US claimed
EP-2380877-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE Kowa Company, Ltd. (JP) 2011-10-26 EP claimed
CN-102227409-A Pyridine-3-carboxyamide derivative KOWA CO 2011-10-26 CN claimed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US claimed
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US disclosed
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US disclosed
US-8575153-B2 Pyridine-3-carboxyamide derivative KOWA COMPANY, LTD. (JP) 2013-11-05 US disclosed
EP-2380877-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE Kowa Company, Ltd. (JP) 2011-10-26 EP disclosed
EP-2380877-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE Kowa Company, Ltd. (JP) 2011-10-26 EP disclosed
CN-102227409-A Pyridine-3-carboxyamide derivative KOWA CO 2011-10-26 CN disclosed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US disclosed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US disclosed
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE KOWA COMPANY, LTD. (JP) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237590-A1 PYRIDINE-3-CARBOXYAMIDE DERIVATIVE JAK3, JAK1, UACA STAT6 8/4885MAPK10 310/4885MAPK9 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.